INS and obesity due to melanocortin 4 receptor deficiency: Recent research has highlighted the pharmacological potential of bibenzyl derivatives in managing metabolic disorders, such as obesity and type 2 diabetes, primarily due to their anti-inflammatory, antioxidant, and insulin-sensitizing properties [18,41,42].